$5.68
-0.14[-2.41%]
At close: Apr 16
$5.68
0[0.00%]
PreMarket: 8:50AM EDT
Candel Therapeutics
(NASDAQ:CADL)Latest News for Candel Therapeutics Stock (NASDAQ:CADL)
Candel Therapeutics Stock (NASDAQ: CADL)
Categories: All
Thursday, April 11, 2024
- Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - 4 days ago
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - 4 days ago
- What's Going On With Candel Therapeutics Stock?Erica Kollmann - 4 days ago
- Candel Therapeutics shares are trading higher after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.Benzinga Newsdesk - 4 days ago
- Candel Therapeutics Receives FDA Orphan Drug Designation For CAN-2409 For The Treatment Of Pancreatic CancerBenzinga Newsdesk - 5 days ago
Tuesday, April 09, 2024
Friday, April 05, 2024
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Apr 5, 2024, 12:31PM
- Candel Therapeutics Shares Resume TradingBenzinga Newsdesk - Apr 5, 2024, 10:17AM
- Candel Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 14.7%Benzinga Newsdesk - Apr 5, 2024, 10:09AM
- Candel Therapeutics Shares Resume TradeBenzinga Newsdesk - Apr 5, 2024, 9:41AM
- Candel Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down -2.81%Benzinga Newsdesk - Apr 5, 2024, 9:37AM
- What's Going On With Candel Therapeutics Stock On Friday?Vandana Singh - Apr 5, 2024, 9:22AM
- CORRECTION: Candel Therapeutics Announced Interim Data From Randomized Phase 2 Clinical Trial Of CAN-2409 In Non-Metastatic Pancreatic Cancer.Benzinga Newsdesk - Apr 5, 2024, 8:57AM
- Candel Therapeutics shares are trading higher on continued strength after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic pancreatic cancer.Benzinga Newsdesk - Apr 5, 2024, 8:52AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Apr 5, 2024, 8:09AM
Thursday, April 04, 2024
- Ford, Candel Therapeutics, Nvidia, Palantir, Tesla: Why These 5 Stocks Are On Investors' Radars TodayBenzinga Neuro - Apr 4, 2024, 11:47PM
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Apr 4, 2024, 4:31PM
- Dow Dips Over 200 Points; RPM International Shares Fall After Q3 ResultsAvi Kapoor - Apr 4, 2024, 2:39PM
- Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 4, 2024, 1:21PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Apr 4, 2024, 12:31PM
- Nasdaq Surges 1%; ConAgra Brands Posts Upbeat EarningsAvi Kapoor - Apr 4, 2024, 11:58AM
- After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer StudyVandana Singh - Apr 4, 2024, 10:24AM
- Market-Moving News for April 4thBenzinga Newsdesk - Apr 4, 2024, 8:33AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Apr 4, 2024, 8:09AM
- Candel Therapeutics Announces Interim Data From Randomized Phase 2 Clinical Trial Of CAN-2409 In Non-Metastatic Pancreatic CancerBenzinga Newsdesk - Apr 4, 2024, 8:04AM
Monday, April 01, 2024
Thursday, March 28, 2024
- Candel Therapeutics Announces Oral Presentation During The 5th Glioblastoma Drug Development Summit With Update On Phase 1b Clinical Trial Of CAN-3110 In Recurrent High-Grade Glioma; Expects To Initiate Investigational New Drug-Enabling Work In A Second Indication Characterized By Nestin ExpressionBenzinga Newsdesk - Mar 28, 2024, 4:17PM
- Recap: Candel Therapeutics Q4 EarningsBenzinga Insights - Mar 28, 2024, 9:40AM
- Candel Therapeutics Reported Q4 EPS Loss of $(0.38) Vs $(0.16) Est, Cash Balance of $35.4MBenzinga Newsdesk - Mar 28, 2024, 7:53AM
Tuesday, February 13, 2024
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Feb 13, 2024, 12:31PM
- Candel Therapeutics Sets Stage For Success With Cancer-Fighting ImmunotherapiesJeremy Golden - Sponsored
- Candel Therapeutics' CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade GliomaBenzinga Newsdesk - Feb 13, 2024, 7:31AM
Monday, February 05, 2024
Wednesday, December 13, 2023
Tuesday, December 12, 2023
- Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Dec 12, 2023, 1:22PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Dec 12, 2023, 12:31PM
- US Stocks Edge Lower; Inflation Rate Slows to 3.1% In NovemberAvi Kapoor - Dec 12, 2023, 9:42AM
- Candel Therapeutics shares are trading higher after the company announced it received FDA Fast Track Designation for CAN-2409 in pancreatic cancer.Benzinga Newsdesk - Dec 12, 2023, 8:25AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Dec 12, 2023, 8:07AM
- Candel Therapeutics Announced That The FDA Granted Fast Track Designation For Its Lead Investigational Adenovirus Asset CAN-2409 Plus Prodrug For The Treatment Of Patients With Pancreatic Ductal AdenocarcinomaBenzinga Newsdesk - Dec 12, 2023, 8:02AM
Tuesday, November 28, 2023
- Candel Therapeutics Shares Resumed TradeBenzinga Newsdesk - Nov 28, 2023, 9:55AM
- Candel Therapeutics Announces Restructuring To Prioritize Resources On Key Value Drivers For Expanded Development Of CAN-3110, The enLIGHTEN Discovery Platform, And Key Clinical Readouts For CAN-2409; Decreases Workforce By ~50%Benzinga Newsdesk - Nov 28, 2023, 9:04AM
- Candel Therapeutics Shares Halted, News PendingBenzinga Newsdesk - Nov 28, 2023, 9:03AM
Monday, November 13, 2023
Thursday, November 09, 2023
Monday, November 06, 2023
- Why Is Cancer Player Candel Therapeutics Stock Trading Higher Today?Vandana Singh - Nov 6, 2023, 1:04PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Nov 6, 2023, 12:31PM
- Candel Therapeutics Presents Preclinical Data from its enLIGHTEN Discovery Platform at SITC; The First Experimental Agent Is Alpha-201-Macro1, An Investigational Viral Immunotherapy Designed To Activate Innate Immune SurveillanceBenzinga Newsdesk - Nov 6, 2023, 8:31AM